Download S. aureus

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
• Antimicrobial Drugs
2008
Antimicrobial Drugs
• Chemotherapy
The use of drugs to treat a
disease
• Antimicrobial drugs
Interfere with the growth of
microbes within a host
• Antibiotic
Substance produced by a
microbe that, in small amounts,
inhibits another microbe
• Selective toxicity
A drug that kills harmful microbes
without damaging the host
2008
• 1928 – Fleming
discovered
penicillin,
produced by
Penicillium.
• 1940 – Howard
Florey and
Ernst Chain
performed first
clinical trials of
penicillin.
2008
Figure 20.1
2008
Table 20.1
2008
Table 20.2
The Action of Antimicrobial Drugs
• Broad-spectrum
• Superinfection
• Bactericidal
• Bacteriostatic
2008
The Action of Antimicrobial Drugs
2008
Figure 20.2
The Action of Antimicrobial Drugs
2008
Figure 20.4
Antibacterial Antibiotics
Inhibitors of Cell Wall Synthesis
• Penicillin
• Natural penicillins
• Semisynthetic penicillins
2008
Penicillins
2008
Figure 20.6
Antibacterial Antibiotics
Inhibitors of Cell Wall Synthesis
• Penicillin
• Penicilinase-resistant penicillins
• Extended-spectrum penicillins
• Penicillins + -lactamase inhibitors
• Carbapenems
• Monobactam
2008
Antibacterial Antibiotics
Inhibitors of Cell Wall Synthesis
2008
Figure 20.8
Antibacterial Antibiotics
Inhibitors of Cell Wall Synthesis
• Cephalosporins
• 2nd, 3rd, and 4th
generations more
effective against
gram-negatives
2008
Figure 20.9
Antibacterial Antibiotics
Inhibitors of Cell Wall Synthesis
• Polypeptide antibiotics
• Bacitracin
• Topical application
• Against gram-positives
• Vancomycin
• Glycopeptide
• Important "last line" against antibiotic resistant S.
aureus
2008
Antibacterial Antibiotics
Inhibitors of Cell Wall Synthesis
• Antimycobacterium antibiotics
• Isoniazid (INH)
• Inhibits mycolic acid synthesis
• Ethambutol
• Inhibits incorporation of mycolic acid
2008
Antibacterial Antibiotics
Inhibitors of Protein Synthesis
• Chloramphenicol
• Broad spectrum
• Binds 50S subunit, inhibits peptide bond
formation
• Aminoglycosides
• Streptomycin, neomycin, gentamycin
• Broad spectrum
• Changes shape of 30S subunit
2008
Antibacterial Antibiotics
Inhibitors of Protein Synthesis
• Tetracyclines
• Broad spectrum
• Interferes with tRNA attachment
• Macrolides
• Gram-positives
• Binds 50S, prevents translocation
• Erythromycin
• Gram-positives
• Binds 50S, prevents translocation
2008
Antibacterial Antibiotics
Inhibitors of Protein Synthesis
• Streptogramins
• Gram-positives
• Binds 50S subunit, inhibits translation
• Synercid
• Gram-positives
• Binds 50S subunit, inhibits translation
• Oxazolidinones
• Linezolid
• Gram-positives
• Binds 50S subunit, prevents formation of 70S
ribosome
2008
Antibacterial Antibiotics
Injury to the Plasma Membrane
• Polymyxin B
• Topical
• Combined with bacitracin and neomycin in overthe-counter preparation
2008
Antibacterial Antibiotics
Inhibitors of Nucleic Acid Synthesis
• Rifamycin
• Inhibits RNA synthesis
• Antituberculosis
• Quinolones and fluoroquinolones
• Ciprofloxacin
• Inhibits DNA gyrase
• Urinary tract infections
2008
Antibacterial Antibiotics
Competitive Inhibitors
• Sulfonamides (Sulfa drugs)
• Inhibit folic acid synthesis
• Broad spectrum
2008
Figure 5.7
2008
Figure 20.13
Antifungal Drugs
Inhibition of Ergosterol Synthesis
• Polyenes
• Amphotericin B
• Azoles
• Miconazole
• Triazoles
• Allylamines
2008
Figure 20.15
Antifungal Drugs
Inhibition of Cell Wall Synthesis
• Echinocandins
• Inhibit synthesis of -glucan
• Cancidas is used against Candida and
Pneumocystis
2008
Antifungal Drugs
Inhibition of Nucleic Acids
• Flucytocine
• Cytosine analog interferes with RNA synthesis
• Pentamidine isethionate
• Anti-Pneumocystis; may bind DNA
2008
Antifungal Drugs
Inhibition of Microtubules (Mitosis)
• Griseofulvin
• Used for superficial mycoses
• Tolnaftate
• Used for athlete's foot; action unknown
2008
Antiviral Drugs
Nucleoside and Nucleotide Analogs
2008
Figure 20.16a
Antiviral Drugs
Nucleoside and Nucleotide Analogs
2008
Figure 20.16b, c
Antiviral Drugs
Enzyme Inhibitors
• Protease inhibitors
• Indinavir
• HIV
• Inhibit attachment
• Zanamivir
• Influenza
• Inhibit uncoating
• Amantadine
• Influenza
• Interferons prevent spread of viruses to new cells
• Viral hepatitis
2008
Antiprotozoan Drugs
• Chloroquine
• Inhibits DNA synthesis
• Malaria
• Diiodohydroxyquin
• Unknown
• Amoeba
• Metronidazole
• Damages DNA
• Entamoeba, Trichomonas
2008
Antihelminthic Drugs
• Niclosamide
• Prevents ATP generation
• Tapeworms
• Praziquantel
• Alters membrane permeability
• Flatworms
• Pyantel pamoate
• Neuromuscular block
• Intestinal roundworms
2008
Antihelminthic Drugs
• Mebendazole
• Inhibits nutrient absorption
• Intestinal roundworms
• Ivermectin
• Paralyzes worm
• Intestinal roundworms
2008
Disk-Diffusion Test
2008
Figure 20.17
E Test
2008
Figure 20.18
• MIC
Minimal inhibitory concentration
• MBC
Minimal bactericidal concentration
2008
Broth Dilution Test
2008
Figure 20.19
2008
Figure 20.20
Antibiotic Resistance
• A variety of mutations can lead to antibiotic resistance.
• Mechanisms of antibiotic resistance
1. Enzymatic destruction of drug
2. Prevention of penetration of drug
3. Alteration of drug's target site
4. Rapid ejection of the drug
• Resistance genes are often on plasmids or
transposons that can be transferred between bacteria.
2008
Antibiotic Resistance
• Misuse of antibiotics selects for resistance mutants.
Misuse includes:
• Using outdated, weakened antibiotics
• Using antibiotics for the common cold and other
inappropriate conditions
• Use of antibiotics in animal feed
• Failure to complete the prescribed regimen
• Using someone else's leftover prescription
2008
Effects of Combinations of Drugs
• Synergism occurs when the effect of two drugs
together is greater than the effect of either alone.
• Antagonism occurs when the effect of two drugs
together is less than the effect of either alone.
2008
Effects of Combinations of Drugs
2008
Figure 20.22
The Future of Chemotherapeutic Agents
• Antimicrobial peptides
• Broad spectrum antibiotics from plants and animals
• Squalamine (sharks)
• Protegrin (pigs)
• Magainin (frogs)
• Antisense agents
• Complementary DNA or peptide nucleic acids that
binds to a pathogen's virulence gene(s) and
prevents transcription
2008
Related documents